Aryl azido-N-hydroxysuccinimide heterobifunctional Crosslinkers

It is expected to help in preparing monoclonal antibody-drug conjugates, which specifically target tumor cells (“20th Century magic bullets” for cancer treatment)

DOWNLOAD FACT SHEET